AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 AUG 13 - (NewsRx.com & NewsRx.net) -- Dendritic cell vaccines offer new hope for the treatment of metastasized endocrine malignancies.
"Dendritic cells (DCs) are antigen-presenting cells that are involved in the induction of primary immune responses. The unique ability of DCs to activate naive and memory CD4+ and CD8+ T cells suggests that they could be used for the induction of a specific antitumor immunity. In the past few years, several in vitro and in vivo studies in rodents and humans have demonstrated that immunizations with DCs pulsed with tumor antigens result in protective immunity and rejection of established tumors in various malignancies," scientists writing in the journal Trends in Endocrinology and Metabolism report.
"Here, we focus on recent results of how DCs regulate immune responses that are important for generating antitumor cytotoxic T cells, and summarize clinical vaccination trials for the treatment of endocrine and nonendocrine carcinomas," stated Matthias Schott and Jochen Seissler at Heinrich-Heine-University Dusseldorf in Germany. "Preliminary results ...
Source: HighBeam Research, Dendritic cell vaccines offer new hope for treatment of endocrine...